UB Paderborn / Katalog / Suche / in CDI

SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset

Blood, 2011-09, Vol.118 (12), p.e50-e61

2011

Link zum Volltext

Verfügbarkeit prüfen

CD14++CD16+ Monocytes Independently Predict Cardiovascular Events

Journal of the American College of Cardiology, 2012-10, Vol.60 (16), p.1512-1520

2012

Link zum Volltext

Verfügbarkeit prüfen

HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease

Journal of the American College of Cardiology, 2017-01, Vol.69 (2), p.246-247

2017

Link zum Volltext

Verfügbarkeit prüfen

Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease

Epigenetics, 2014-01, Vol.9 (1), p.161-172

2014

Link zum Volltext

Verfügbarkeit prüfen

PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR

PloS one, 2016-01, Vol.11 (1), p.e0146920-e0146920

2016

Link zum Volltext

Verfügbarkeit prüfen

Distinct immunologic effects of different intravenous iron preparations on monocytes

Nephrology, dialysis, transplantation, 2014-04, Vol.29 (4), p.809-822

2014

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol Synthesis, Cholesterol Absorption, and Mortality in Hemodialysis Patients

Clinical journal of the American Society of Nephrology, 2012-06, Vol.7 (6), p.943-948

2012

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation

Epigenetics, 2016-04, Vol.11 (4), p.259-272

2016

Link zum Volltext

Verfügbarkeit prüfen

The relationships of markers of cholesterol homeostasis with carotid intima-media thickness

PloS one, 2010-10, Vol.5 (10), p.e13467-e13467

2010

Link zum Volltext

Verfügbarkeit prüfen

Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study

Pharmacology research & perspectives, 2021-08, Vol.9 (4), p.e00801-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

CD14++CD16+ Monocytes Independently Predict Cardiovascular Events: A Cohort Study of 951 Patients Referred for Elective Coronary Angiography

Journal of the American College of Cardiology, 2012-10, Vol.60 (16), p.1512-1520

2012

Link zum Volltext

Verfügbarkeit prüfen

Single FGF-23 Measurement and Time-Averaged Plasma Phosphate Levels in Hemodialysis Patients

Clinical journal of the American Society of Nephrology, 2013-10, Vol.8 (10), p.1764-1772

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the Performance of 2 GFR Estimating Equations Using Creatinine and Cystatin C to Predict Adverse Outcomes in Elderly Individuals

American journal of kidney diseases, 2015-04, Vol.65 (4), p.636-638

2015

Link zum Volltext

Verfügbarkeit prüfen

CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease

European heart journal, 2011, Vol.32 (1), p.84-92

2011

Link zum Volltext

Verfügbarkeit prüfen

Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4

Clinical journal of the American Society of Nephrology, 2014-06, Vol.9 (6), p.1049-1058

2014

Link zum Volltext

Verfügbarkeit prüfen

Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease

Arteriosclerosis, thrombosis, and vascular biology, 2014-09, Vol.34 (9), p.2120

2014

Link zum Volltext

Verfügbarkeit prüfen

Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations

Pharmacology & therapeutics (Oxford), 2020-03, Vol.207, p.107459-107459, Article 107459

2020

Link zum Volltext

Verfügbarkeit prüfen

Lipid management 2020 - medical therapy and lipid apheresis in context

Deutsche medizinische Wochenschrift (1946), 2020-04, Vol.145 (7), p.464

2020

Link zum Volltext

Verfügbarkeit prüfen

Monocyte heterogeneity in human cardiovascular disease

Immunobiology (1979), 2012-12, Vol.217 (12), p.1273-1284

2012

Link zum Volltext

Verfügbarkeit prüfen

NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4

Clinical journal of the American Society of Nephrology, 2016-11, Vol.11 (11), p.1978-1988

2016

Link zum Volltext

Verfügbarkeit prüfen

Monocyte heterogeneity in obesity and subclinical atherosclerosis

European heart journal, 2010-02, Vol.31 (3), p.369-376

2010

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppression and monocyte subsets

Nephrology, dialysis, transplantation, 2015-01, Vol.30 (1), p.143-153

2015

Link zum Volltext

Verfügbarkeit prüfen

Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients

Seminars in dialysis, 2017-09, Vol.30 (5), p.390-394

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of two different strategies for human monocyte subsets gating within the large‐scale prospective CARE FOR HOMe Study

Cytometry. Part A, 2015-08, Vol.87 (8), p.750-758

2015

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA profiling of human intermediate monocytes

Immunobiology (1979), 2017-03, Vol.222 (3), p.587-596

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset

CD14++CD16+ Monocytes Independently Predict Cardiovascular Events

HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease

Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease

PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR

Distinct immunologic effects of different intravenous iron preparations on monocytes

Cholesterol Synthesis, Cholesterol Absorption, and Mortality in Hemodialysis Patients

DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation

The relationships of markers of cholesterol homeostasis with carotid intima-media thickness

Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study

CD14++CD16+ Monocytes Independently Predict Cardiovascular Events: A Cohort Study of 951 Patients Referred for Elective Coronary Angiography

Single FGF-23 Measurement and Time-Averaged Plasma Phosphate Levels in Hemodialysis Patients

Comparison of the Performance of 2 GFR Estimating Equations Using Creatinine and Cystatin C to Predict Adverse Outcomes in Elderly Individuals

CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease

Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4

Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease

Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations

Lipid management 2020 - medical therapy and lipid apheresis in context

Monocyte heterogeneity in human cardiovascular disease

NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4

Monocyte heterogeneity in obesity and subclinical atherosclerosis

Immunosuppression and monocyte subsets

Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients

Comparison of two different strategies for human monocyte subsets gating within the large‐scale prospective CARE FOR HOMe Study

MicroRNA profiling of human intermediate monocytes

Suchergebnisse filtern